Merck (NYSE:MRK) led a $15 million Series B round for Medivo and its health data analytics platform.
The round was also backed by repeat investors Safeguard Scientifics (NYSE:SFE) and MentorTech Ventures. Medivo has raised a total of $22 million to support its module for health analytics, which the company touts as HIPAA-compliant and user-friendly for physicians and patients.
"Health information technology is one of the prime investment areas for Merck’s Global Health Innovation Fund, and Medivo’s technology and analytics platform are at the forefront of innovation in this space," said Merck Global Health Innovation fund investor Joe Volpe in prepared remarks.
Safeguard led a $7 million Series A round for Medivo in 2011.
